Immucell (ICCC) Revenue (2010 - 2026)
Immucell (ICCC) reported Revenue of $7.19 million for Q2 2026, up 11.5% from $6.44 million a year earlier.
Powered by 
Analysis
Immucell (ICCC) Revenue (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Immucell's Revenue came in at $26.76 million, down 5.3% year-over-year; for FY2025, it came in at $27.64 million, up 4.3% from FY2024.
- Revenue has a five-year compound annual growth rate of 12.5% (FY2020 to FY2025).
- By year, Revenue came in at $26.49 million in FY2024 (+51.6%), $17.47 million in FY2023 (-5.9%), $18.57 million in FY2022 (-3.5%) and $19.24 million in FY2021 (+25.4%).
- Five-year quarterly Revenue spans a low of $3.45 million in Q1 2023 and a high of $8.07 million in Q1 2025.
- Year over year, Revenue gained in four of the last six quarters, with growth averaging 7.0%.
- The high point for year-over-year Revenue in five years was Q1 2024 (growth of 110.6%); the low point was Q1 2023 (a decline of 42.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 25.40 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Immucell | 94.82 Mn | 72.27 Mn | 2.44 Mn | 7.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.19 Mn |
| Dec 31, 2025 | 7.63 Mn |
| Sep 30, 2025 | 5.51 Mn |
| Jun 30, 2025 | 6.44 Mn |
| Mar 31, 2025 | 8.07 Mn |
| Dec 31, 2024 | 7.75 Mn |
| Sep 30, 2024 | 6.01 Mn |
| Jun 30, 2024 | 5.47 Mn |
| Mar 31, 2024 | 7.26 Mn |
| Sep 30, 2023 | 5.40 Mn |
| Jun 30, 2023 | 3.53 Mn |
| Mar 31, 2023 | 3.45 Mn |
| Dec 31, 2022 | 3.91 Mn |
| Sep 30, 2022 | 4.80 Mn |
| Jun 30, 2022 | 3.86 Mn |
| Mar 31, 2022 | 6.00 Mn |
| Dec 31, 2021 | 5.44 Mn |
| Sep 30, 2021 | 5.15 Mn |
| Jun 30, 2021 | 4.54 Mn |
| Mar 31, 2021 | 4.11 Mn |
API Access
Immucell Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=ICCC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "ICCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=ICCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();